Loading clinical trials...
Loading clinical trials...
The SIIR during neoadjuvant therapy can serve as a specific biomarker for predicting the efficacy of immunotherapy in patients with advanced gastric cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chang-Ming Huang, Prof.
NCT07550023 · Short Chain Fatty Acids Concentration in Stools, Gut Microbiota Diversity and Composition, and more
NCT04421820 · Colorectal Cancer, Pancreatic Cancer, and more
NCT06817252 · Prediabetes, Lipid Profile, and more
NCT01416714 · Gastric Cancers
NCT06895447 · Gastric Cancers
Fujian Medical University Union Hospital
Fuzhou, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions